NEW THESIS ·
Open Oral and Generic Obesity Drugs: Can More People Stay on Paid Treatment at Lower Cost?
New pills, generics and coverage programs widen the route into obesity treatment. Can more people stay treated at a lower full cost?
N-LEDGER · THE NKENGBEZA LEDGER · INDEPENDENT RESEARCH
Discover the Catalyst. Test the Commercial Impact. Track the Outcome.
Evidence-led research on discoveries, launches and deals that could reshape earnings across science, technology and finance.
ON THE LEDGER
Web updates
What is new in the research, trackers and on the site.
LATEST ACTIVITY20 most recent · scroll to explore
NEW THESIS ·
Open Driverless Transport: Can Driver-Out Service Become Repeatable, Safe and Economic?
Driverless service is carrying riders and freight. The next test is whether it can repeat safe, useful work at a sustainable full cost.
NEW THESIS ·
Open Long-Acting HIV Prevention From Three Developers: Can Access Commitments Become Covered Person-Time Where Infections Are Highest?
Three developer branches have different rollout stages. The thesis measures sustained, schedule-covered person-time and financed full service cost, rather than treating trials, pledges or starts as delivered protection.
NEW THESIS ·
Open Next-Generation Geothermal: Can Independent Developers Deliver Reliable Net Power at Financeable Cost?
Four developers reached dated catalysts with different mechanisms. Only Fervo's first Cape block has a contract-recognized commercial record; metered net output and full-project cost remain open.
NEW THESIS ·
Open Africa AI: Is Local Compute Turning Into Local Revenue?
Local AI capacity is installed and offered in South Africa; paid production use and retained local revenue remain unproven.
OCCURRENCE LEDGER · · Individual
Open New occurrence receipt
An Individual-access receipt was added to the ledger.
NEW THESIS ·
Open Kyverna: Can One Miv-cel Infusion Sustain Function Without Chronic Immunotherapy in Refractory Stiff-Person Syndrome?
A free Medicine thesis tracking an incomplete SPS BLA, the FDA decision, and whether single-arm clinical gains persist in commercial care.
COMMENTARY ·
Open Micron Technology, Inc.: quarterly commentary
June 24 detailed quarterly program disclosure
COMMENTARY ·
Open Micron Technology, Inc.: quarterly commentary
September 30 quarterly management update
COMMENTARY ·
Open MP Materials Corp.: quarterly commentary
Q2 2026 Independence magnet qualification statement
OCCURRENCE LEDGER ·
Open Strategic customer agreements and pricing-cycle durability
Micron Technology, Inc. · A dated receipt is available against its locked question.
NEW THESIS ·
Open Micron: Can Strategic Customer Agreements Make Its Memory Earnings Less Cyclical?
A free thesis testing whether strategic customer agreements can make Micron's memory earnings less cyclical.
OCCURRENCE LEDGER · · Individual
Open New occurrence receipt
An Individual-access receipt was added to the ledger.
NEW THESIS ·
Open MP Materials: Can Independence Turn GM Magnet Qualification Into Recurring Finished-Magnet Sales and Durable Segment Economics?
A free thesis tracking commercial finished-magnet delivery to GM, repeat sales and Magnetics economics after the finite precursor stream runs off.
OCCURRENCE LEDGER ·
Open INTerpath-001 Phase 3 interim topline
Moderna, Inc. · A dated receipt is available against its locked question.
CATALYST RADAR ·
Open INTerpath-001 Phase 3 interim topline
Moderna, Inc. · Owner-approved four-star catalyst thesis; screening and occurrence are not an outcome grade.
NEW THESIS ·
Open Moderna: Can Phase 3 Intismeran Success Convert Personalized mRNA Cancer Therapy Into a Scalable Oncology Franchise?
Read the published thesis, dated evidence and tracking record.
FILING CHANGES · · Professional
Open Filing comparison added
A new source-linked comparison is available to Professional readers.
NEW THESIS ·
Open Applied Digital: Can Polaris Forge 2 Convert Oracle's AI Infrastructure Commitment Into Durable Returns Above Its Capital Cost?
A subscriber thesis testing whether Polaris Forge 2 can convert its Oracle lease into durable cash returns above financing claims.
FILING CHANGES · · Professional
Open Filing comparison added
A new source-linked comparison is available to Professional readers.
Prospective record
Active research
Latest published thesisMedicine
Oral and Generic Obesity Drugs: Can More People Stay on Paid Treatment at Lower Cost?
New pills, generics and coverage programs widen the route into obesity treatment. Can more people stay treated at a lower full cost?
PublishedOctober 24, 2026
Open thesis →Prospective recordMarket catalyst
Oral and Generic Obesity Access
Read the thesis question, source record and dated tracking history in the publication.
Browse all published research →SOFTWARE · PUBLISHED OCTOBER 24, 2026
Open thesis →Driverless Transport: Can Driver-Out Service Become Repeatable, Safe and Economic?
MEDICINE · PUBLISHED OCTOBER 24, 2026
Open thesis →Long-Acting HIV Prevention From Three Developers: Can Access Commitments Become Covered Person-Time Where Infections Are Highest?
HARDWARE · PUBLISHED OCTOBER 24, 2026
Open thesis →Next-Generation Geothermal: Can Independent Developers Deliver Reliable Net Power at Financeable Cost?
FREE READER UPDATES
Follow the work without creating an account.
Choose email, text messages, or both. Select only the updates you want. Each channel must be confirmed before delivery begins.